Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
Research News
Conference News
Plain English
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
What We Know
Animal Models
Drugs in Trials
Research Tools
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.

Kao SC, Wu H, Xie J, Chang CP, Ranish JA, Graef IA, Crabtree GR. Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science . 2009 Jan 30 ; 323(5914):651-4. PubMed Abstract

Comments on Paper and Primary News
Comment by:  Markus Schwab
Submitted 13 February 2009 Posted 13 February 2009

Understanding signaling pathways that control myelination is essential to develop therapies for human diseases, which are associated with de- or dysmyelination, such as schizophrenia. In a recent paper in Science, the laboratories of Isabella Graef and Gerald Crabtree at Stanford University have now identified the Ca+-dependent phosphatase salcineurin and downstream transcription factor NFATc3 as an important signaling pathway for Schwann cell (SC) myelination in vivo. In mouse mutants lacking calcineurin, SC differentiation and early steps of myelination are defective. They also offer an exciting link to the neuregulin1-ErbB signaling pathway, which is essential for peripheral myelination. They demonstrate that in vitro NRG1 stimulates phospholipaseγ-dependent Ca+ influx into SC precursors and calcineurin-dependent dephosphorylation of NFATc3, which activates transcription of Krox-20, an important coordinator of myelin protein expression. Since NRG1 and calcineurin variants have been associated with schizophrenia and are expressed in various brain regions, e.g., the...  Read more

View all comments by Markus Schwab
Submit a Comment on this Paper
Make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend this paper

Please note: A member needs to be both registered and logged in to submit a comment.


(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)


SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright